| | | | | |
| €27,2196 | -0,22 % | €240,25M | €28,13K | |
DBL DOUBLELINE OPPORTUNISTIC CREDIT FUND | €12,1109 | +0,57 % | €239,96M | €59,49K | |
TSI TCW Strategic Income Fund, Inc. | €3,7686 | +0,46 % | €239,56M | €132,12K | |
PAII Pyrophyte Acquisition Corp. II | €8,8091 | +0,15 % | €239,14M | €1,41K | |
| €12,2308 | +2,00 % | €239,03M | €197,75K | |
YDES YD Bio Limited Ordinary Shares | €3,9827 | -0,22 % | €239,02M | €8,03K | |
XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares | €8,6035 | +0,55 % | €238,72M | €5,11K | |
RWAY Runway Growth Finance Corp. Common Stock | €5,6186 | -0,15 % | €238,70M | €316,34K | |
JILL J.Jill, Inc. Common Stock | €16,9244 | -1,25 % | €238,70M | €35,79K | |
LCTX Lineage Cell Therapeutics, Inc. | €0,96785 | +3,67 % | €238,27M | €883,87K | |
AXIN Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares | €8,8348 | -0,05 % | €238,20M | €132,49K | |
ACV Virtus Diversified Income & Convertible Fund | €22,7486 | +0,38 % | €238,18M | €36,16K | |
ALXO ALX Oncology Holdings Inc. Common Stock | €1,7087 | +0,25 % | €238,05M | €399,09K | |
| €1,2248 | +2,14 % | €237,96M | €462,77K | |
YSG Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares | €2,5352 | -1,33 % | €237,81M | €38,99K | |
